Time for a low-risk DCIS trial: Harnessing public and patient involvement

The Lancet Oncology

Volumn 13, Issue 12, 2012, Pages 1183-1185

  Fallowfield, Lesley ^a   Francis, Adele ^b   Catt, Susan ^a   MacKenzie, Mairead ^c   Jenkins, Valerie ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c Independent Cancer Patients' Voice   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED RADIOTHERAPY; HUMAN; INTRADUCTAL CARCINOMA; LETTER; MASTECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENCE RISK;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; PATIENT SELECTION; WATCHFUL WAITING;

EID: 84870244595     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70503-X     Document Type: Letter

References (10)

1. The benefits and harms of breast cancer screening: an independent review. Lancet 2012, Independent UK Panel on Breast Cancer Screening, published online Oct 30. http://dx.doi.org/10.1016/S0140-6736(12)61611-0.
2. Duffy SW, Tabar L, Olsen AH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010, 17:25-30.
3. What is ductal carcinoma in situ (DCIS)? Anon, (accessed Sept 20, 2012). http://www.healthtalkonline.org/Cancer/ductal_carcinoma_in_situ/Topic/3566/.
4. De Morgan S, Redman S, D'Este C, Rogers K Knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS). Patient Educ Couns 2011, 84:62-68.
5. Cook RC, Alscher KT, Hsiang YN A debate on the value and necessity of clinical trials in surgery. Am J Surg 2003, 185:305-310.
6. Fallowfield L, Jenkins V, Farewell V, Saul J, Duffy A, Eves R Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial. Lancet 2002, 359:650-656.
7. Jenkins V, Fallowfield LJ, Solis-Trapala I, Langridge C, Farewell V Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. BMJ 2005, 330:400.
8. Fallowfield LJ, Solis-Trapala I, Jenkins V Evaluation of an educational program to improve communication with patients about early-phase trial participation. Oncologist 2012, 17:377-383.
9. Donovan JL, Athene Lane J, Peters T, et al. Development of a complex intervention improved randomisation and informed consent in a randomised controlled trial. J Clin Epidemiol 2009, 62:29-36.
10. Smith R Communicating with patients about ductal carcinoma in situ. BMJ Group Blogs, 2011 (accessed Sept 28, 2012). http://blogs.bmj.com/bmj/2011/09/07/richard-smith-communicating-with-patients-about-ductal-carcinoma-in-situ/.